Advertisement

Topics

Ipsen CEO To Feed Group's Three Therapeutic Engines Fresh Assets In 2018

08:09 EST 15 Feb 2018 | SCRIP

CEO David Meek Says Ipsen has more than $1bn for M&A use to expand its product line in oncology, neuroscience...

      

Related Stories

 

Original Article: Ipsen CEO To Feed Group's Three Therapeutic Engines Fresh Assets In 2018

NEXT ARTICLE

More From BioPortfolio on "Ipsen CEO To Feed Group's Three Therapeutic Engines Fresh Assets In 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...